Inventor
BLANCHE FRANCIS
FR40 patents
⚠️ This page may combine multiple inventors who share the name “BLANCHE FRANCIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA SA
10 patentsUS6319672B1Nov 20, 2001
Purification of a triple helix formation with an immobilized oligonucleotide
AVENTIS PHARMA SA16 citations92
US6207150B1Mar 27, 2001
Variants of thymidine kinase, nucleic acids encoding them, and methods of using them
AVENTIS PHARMA SA32 citations91
US6537793B2Mar 25, 2003
Method of separating viral particles
AVENTIS PHARMA SA44 citations89
US6518062B1Feb 11, 2003
Enzyme combinations for destroying proliferative cells
AVENTIS PHARMA SA9 citations72
US6352839B1Mar 5, 2002
Streptogramins for preparing same by mutasynthesis
AVENTIS PHARMA SA9 citations72
US6153597ANov 28, 2000
Pharmaceutical composition useful for nucleic acid transfection, and use thereof
AVENTIS PHARMA SA13 citations72
US6833382B2Dec 21, 2004
Streptogramins and method for preparing same by mutasynthesis
AVENTIS PHARMA SA3 citations61
US6670157B1Dec 30, 2003
Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
AVENTIS PHARMA SA2 citations60
US6171846B1Jan 9, 2001
Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
AVENTIS PHARMA SA3 citations60
US6649394B1Nov 18, 2003
Topoisomerase IV, corresponding nucleotide sequences and uses thereof
AVENTIS PHARMA SA0 citations49
SANOFI SA
8 patentsUS9617345B2Apr 11, 2017
Anti-CEACAM5 antibodies and uses thereof
SANOFI SA53 citations95
US10457739B2Oct 29, 2019
Anti-CEACAM5 antibodies and uses thereof
SANOFI SA6 citations82
US11332542B2May 17, 2022
Anti-CEACAM5 antibodies and uses thereof
SANOFI SA4 citations71
US10112991B2Oct 30, 2018
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
SANOFI SA2 citations71
US9382312B2Jul 5, 2016
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
SANOFI SA2 citations61
US12570761B2Mar 10, 2026
Anti-CEACAM5 antibodies and uses thereof
SANOFI SA0 citations60
US9441040B2Sep 13, 2016
Antagonist antibodies and their fab fragments against GPVI and uses thereof
SANOFI SA0 citations50
US9809653B2Nov 7, 2017
Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof
SANOFI SA1 citations42
CENTELION
6 patentsUS6905862B2Jun 14, 2005
Method for producing recombinant adenovirus
CENTELION13 citations81
US7038026B2May 2, 2006
Purification of a triple heli formation with an immobilized oligonucleotide
CENTELION10 citations73
US8017744B2Sep 13, 2011
Purification of a triple helix formation with an immobilized oligonucleotide
CENTELION1 citations62
US7514218B2Apr 7, 2009
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
CENTELION0 citations52
US7052838B2May 30, 2006
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
CENTELION0 citations52
US7202078B2Apr 10, 2007
Composition intended for the preservation of infectious recombinant adenoviruses
CENTELION0 citations46
RHONE POULENC RORER SA
4 patentsUS5891695AApr 6, 1999
Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
RHONE POULENC RORER SA9 citations71
US6001631ADec 14, 1999
Topoisomerase IV, corresponding nucleotide sequences and uses thereof
RHONE POULENC RORER SA7 citations70
US5591614AJan 7, 1997
Process for the enzymatic preparation of macrolactone
RHONE POULENC RORER SA6 citations62
US6156545ADec 5, 2000
Biosynthesis method enabling the preparation of cobalamins
RHONE POULENC RORER SA3 citations61
GENCELL SA
3 patentsUS6485958B2Nov 26, 2002
Method for producing recombinant adenovirus
GENCELL SA103 citations95
US6825012B2Nov 30, 2004
DNA molecules, preparation and use in gene therapy
GENCELL SA5 citations62
US6734008B2May 11, 2004
Composition intended for the preservation of infectious recombinant adenoviruses
GENCELL SA3 citations56
BLANCHE FRANCIS
3 patentsUS9493529B2Nov 15, 2016
Robo1-Fc fusion protein and use thereof for treating tumours
BLANCHE FRANCIS20 citations87
US8119770B2Feb 21, 2012
Modified soluble FGF receptor Fc fusions with improved biological activity
BLANCHE FRANCIS19 citations86
US8481487B2Jul 9, 2013
Modified soluble FGF receptor Fc fusions method
BLANCHE FRANCIS0 citations46